knowledge -WSS

knowledge

author：comprehensive 2025-09-03 11:49:42 - browse：4817

Sutter Health Palo Alto Medical Foundation facilities. health tech coverage from STAT — Adobe

When Sutter Health was on trial for anticompetitive conduct in 2022, the San Francisco jury missed out on some crucial details. They didn’t hear, for example, how its former finance chief said the system would make an extra $200 million per year by making insurers contract with all of its hospitals instead of just a few. Or how its former CEO said, “Related to the health plans, we force them to pay us more.”

That evidence was indeed relevant, and the judge erred by not allowing it to be presented during the month-long trial that concluded in March 2022, a U.S. appeals court wrote in its ruling on Tuesday. The Ninth Circuit panel overturned Sutter’s win in the class-action case alleging that Sutter used its market power to drive up health care costs across the region by more than $400 million. Tuesday’s decision means the case will likely get a second trial.

“Effectively, the appellate court said the jury was tainted,” said Matthew Cantor, lead counsel for the plaintiffs. “So the jury’s verdict is discarded.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Asbestos, a deadly carcinogen, banned by EPA

WSS

Colonoscopy prep: Liquid

Diabetes management: Digital health tools fall short, study says

U.K. researchers warn about biases in medical devices, algorithms

With Wegovy coverage, Medicare patients may face high costs

5 to watch: Tech startups trying to solve health care's staffing crisis

With Wegovy coverage, Medicare patients may face high costs

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

entertainment

In Memoriam: Notable people who died in 2023

What Kate Middleton's cancer revelation might teach the world

Trump demands the U.S. pay no more for drugs than other countries … again

Steward Health Care expansion into Malta flopped

Guidelines to prevent youth baseball injuries need more muscle

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Drug repurposing or repositioning? The language matters

CRISPR technology availability, affordability needs to be expanded

ChatGPT in medicine: STAT answers readers' burning questions

Baby aspirin cuts fat buildup in liver disease patients, in small study

hotspot

Orchard's therapy for neuron disease in children wins FDA approval

U.K. researchers warn about biases in medical devices, algorithms

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

With Wegovy coverage, Medicare patients may face high costs

Methadone treatment changes are coming. Do they go far enough?

6 surprising facts about sugar

focus

focus

leisure time

hotspot